• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?在前列腺癌患病率较低的国家，共同决策是否会提高前列腺筛查的接受率？
Afr Health Sci. 2020 Dec;20(4):1870-1874. doi: 10.4314/ahs.v20i4.43.
2
Disparities Associated with Shared Decision-making in Prostate Cancer Screening.前列腺癌筛查中与共同决策相关的差异。
Eur Urol Focus. 2023 Nov;9(6):1008-1015. doi: 10.1016/j.euf.2023.04.013. Epub 2023 May 15.
3
Shared decision making in prostate-specific antigen testing with men older than 70 years.70 岁以上男性前列腺特异性抗原检测的共同决策。
J Am Board Fam Med. 2013 Jul-Aug;26(4):401-8. doi: 10.3122/jabfm.2013.04.120267.
4
Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.前列腺特异性抗原检测的启动和共享决策：来自 2000 年和 2015 年国家健康访谈调查的发现。
J Am Board Fam Med. 2018 Jul-Aug;31(4):658-662. doi: 10.3122/jabfm.2018.04.170448.
5
National evidence on the use of shared decision making in prostate-specific antigen screening.国家关于在前列腺特异性抗原筛查中使用共同决策的证据。
Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.
6
Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.男性是否获得了关于前列腺特异性抗原（PSA）检测共同决策所需的信息？一项全国性调查的结果。
J Cancer Educ. 2016 Dec;31(4):693-701. doi: 10.1007/s13187-015-0870-8.
7
Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.健康素养对美国前列腺特异性抗原筛查中共同决策的影响。
Cancer. 2021 Jan 15;127(2):249-256. doi: 10.1002/cncr.33239. Epub 2020 Nov 9.
8
Limited Evidence of Shared Decision Making for Prostate Cancer Screening in Audio-Recorded Primary Care Visits Among Black Men and their Healthcare Providers.在黑人男性及其医疗保健提供者的初级保健就诊中，音频记录的前列腺癌筛查中共享决策的证据有限。
J Immigr Minor Health. 2024 Oct;26(5):866-877. doi: 10.1007/s10903-024-01606-5. Epub 2024 Jun 1.
9
Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.聋人和听力正常男性患者的前列腺特异性抗原（PSA）筛查与共同决策
J Cancer Educ. 2020 Feb;35(1):28-35. doi: 10.1007/s13187-018-1436-3.
10
"Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?“共同决策”用于前列腺癌筛查：是否为高质量预防性保健的标志？
Cancer Epidemiol. 2024 Feb;88:102492. doi: 10.1016/j.canep.2023.102492. Epub 2023 Dec 5.

引用本文的文献

1
Factors Influencing Patient-Centered Care and Shared Decision-Making in Primary Care Settings in Saudi Arabia: A Scoping Review.影响沙特阿拉伯基层医疗环境中以患者为中心的护理和共同决策的因素：一项范围综述
Cureus. 2024 Dec 21;16(12):e76142. doi: 10.7759/cureus.76142. eCollection 2024 Dec.
2
Shared decision-making before prostate cancer screening decisions.前列腺癌筛查决策前的共同决策。
Nat Rev Urol. 2024 Jun;21(6):329-338. doi: 10.1038/s41585-023-00840-0. Epub 2024 Jan 2.
3
Editor's choice: this December 2020.编辑推荐：2020年12月
Afr Health Sci. 2020 Dec;20(4):ii-v. doi: 10.4314/ahs.v20i4.2.

本文引用的文献

1
Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.美国前列腺特异性抗原检测中共同决策模式的最新变化。
Ann Fam Med. 2018 Mar;16(2):139-144. doi: 10.1370/afm.2200.
2
Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.男性是否获得了关于前列腺特异性抗原（PSA）检测共同决策所需的信息？一项全国性调查的结果。
J Cancer Educ. 2016 Dec;31(4):693-701. doi: 10.1007/s13187-015-0870-8.
3
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡：GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
4
National evidence on the use of shared decision making in prostate-specific antigen screening.国家关于在前列腺特异性抗原筛查中使用共同决策的证据。
Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.
5
Primary care physicians' use of an informed decision-making process for prostate cancer screening.初级保健医生在前列腺癌筛查中使用知情决策过程。
Ann Fam Med. 2013 Jan-Feb;11(1):67-74. doi: 10.1370/afm.1445.
6
Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.基于实践的两项随机对照试验联合分析：前列腺癌筛查中共同决策的结果。
BMC Med Inform Decis Mak. 2012 Nov 13;12:130. doi: 10.1186/1472-6947-12-130.
7
International variation in prostate cancer incidence and mortality rates.前列腺癌发病率和死亡率的国际差异。
Eur Urol. 2012 Jun;61(6):1079-92. doi: 10.1016/j.eururo.2012.02.054. Epub 2012 Mar 8.
8
Shared decision making--pinnacle of patient-centered care.共同决策——以患者为中心的医疗的巅峰。
N Engl J Med. 2012 Mar 1;366(9):780-1. doi: 10.1056/NEJMp1109283.
9
Shared decision making: really putting patients at the centre of healthcare.共同决策：真正将患者置于医疗保健的中心。
BMJ. 2012 Jan 27;344:e256. doi: 10.1136/bmj.e256.
10
Association of physicians' knowledge and behavior with prostate cancer counseling and screening in Saudi Arabia.沙特阿拉伯医生的知识与行为与前列腺癌咨询及筛查的关联
Saudi Med J. 2010 Nov;31(11):1245-50.

在前列腺癌患病率较低的国家，共同决策是否会提高前列腺筛查的接受率？

Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?

作者信息

Amin Hussein Saad, Arafa Mostafafa Ahmed, Farhat Karim Hamda, Rabah Danny Munther, Altaweel Abdulaziz Abdullah, Alhammad Abdulaziz Hamed

机构信息

Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Cancer Research Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Afr Health Sci. 2020 Dec;20(4):1870-1874. doi: 10.4314/ahs.v20i4.43.

DOI:10.4314/ahs.v20i4.43
PMID:34394251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8351862/
Abstract

BACKGROUND

Men over 50 should discuss the benefits and harms of prostate-specific antigen (PSA) testing with their doctors.

OBJECTIVES

To investigate whether shared decision making (SDM) increases the uptake of prostate cancer screening practices among Saudi men.

METHODS

This community-based study recruited men aged ≥ 50 years between January and April 2019. Sociodemographic characteristics, history, and current medical condition information were collected. SDM information with regards to prostate cancer screening was discussed.

RESULTS

In total, 2034 Saudi men, aged between 50 and 88 years, agreed to participate in the current study. Prostate examination for early detection of cancer was recommended for 35.4% (720) of subjects. Of the subjects, 23.3% (473) reported that the physicians discussed the advantages and benefits of PSA testing, whereas only 5.6% (114) stated that the physicians explained the disadvantages and drawbacks of PSA testing.

CONCLUSION

Our findings suggest that less than one fourth discussed the advantages and disadvantages of PSA testing with their physicians; of these, less than one third underwent PSA blood tests. Improvements are needed in SDM for and against PSA screening. SDM does not affect the intensity of PSA testing. Primary health care physicians should be actively involved in the SDM process.

摘要

背景

50岁以上男性应与医生讨论前列腺特异性抗原（PSA）检测的利弊。

目的

调查共同决策（SDM）是否能提高沙特男性对前列腺癌筛查措施的接受程度。

方法

这项基于社区的研究在2019年1月至4月招募了年龄≥50岁的男性。收集了社会人口学特征、病史和当前医疗状况信息。讨论了有关前列腺癌筛查的共同决策信息。

结果

共有2034名年龄在50至88岁之间的沙特男性同意参与本研究。35.4%（720名）受试者被建议进行前列腺检查以早期发现癌症。在这些受试者中，23.3%（473名）报告称医生讨论了PSA检测的优势和益处，而只有5.6%（114名）表示医生解释了PSA检测的劣势和缺点。

结论

我们的研究结果表明，不到四分之一的人与其医生讨论了PSA检测的优缺点；其中，不到三分之一的人接受了PSA血液检测。在支持和反对PSA筛查的共同决策方面需要改进。共同决策不会影响PSA检测的强度。初级保健医生应积极参与共同决策过程。